The latest BTOS survey reveals a stark divide in AI adoption across industries and regions, raising questions about economic inequality and the future of work.
In a pivotal meeting, Anthropic's CEO discusses the groundbreaking AI model Mythos with top officials, raising questions about its potential and risks.
OpenAI's GPT-Rosalind is set to revolutionize drug discovery, promising to accelerate timelines and reduce costs while raising important ethical questions.